TNNT2 and hydrops fetalis: We show in this study for the first time that there is a significant association between the plasma hs-cTnT measured at baseline with change in LVEF over time, highlighting a potentially important role for hs-cTnT as a biomarker for assessing HF risk in patients with T2D.